PCN14 A MODELTO DEMONSTRATE THE COMPARATIVE COSTS BETWEEN PANITUMUMAB AND CETUXIMAB FOR THIRD-LINE METASTATIC COLORECTAL CANCER PATIENTS IN ITALY
Abstract
Authors
H Lamarque JW Fitzgibbon BJ Farrimond RJB Lavelle SG Eggington A Bracco